Florida Oncology Partners (Tables) (FOP and FOPRE [Member])

6 Months Ended

Jun. 30, 2013

FOP and FOPRE [Member]

Schedule of Equity Method Investments [Line Items]

Summarized Financial Information

The following tables present the aggregation of summarized financial information of FOP and FOPRE:

FOP and FOPRE Condensed Income Statement Information

	Six Months Ended
	June 30,
	2013		2012
Patient revenue	$	1,469,000	$	1,483,000
Rental income	$	90,000	$	-
Net sales	$	1,559,000	$	1,483,000
Net income	$	81,000	$	186,000
USNC's equity in income of FOP and FOPRE	$	16,000	$	37,000

	Three Months Ended
	June 30,
	2013		2012
Patient revenue	$	812,000	$	922,000
Rental income	$	45,000	$	-
Net sales	$	857,000	$	922,000
Net income	$	116,000	$	250,000
USNC's equity in income of FOP and FOPRE	$	23,000	$	50,000

FOP and FOPRE Condensed Balance Sheet Information

	June 30,		December 31,
	2013		2012
Current assets	$	1,206,000	$	919,000
Noncurrent assets	$	6,121,000	$	6,374,000
Total assets	$	7,327,000	$	7,293,000
Current liabilities	$	1,332,000	$	965,000
Noncurrent liabilities	$	5,320,000	$	5,734,000
Equity	$	675,000	$	594,000
Total liabilities and equity	$	7,327,000	$	7,293,000